Safety of continuous use of Apixaban, Rivaroxaban and Dabigatran in patients undergoing cardiac implantable electronic device implantation in a real-world cohort
25 August 2018 (00:00 - 00:00)
Organised by:
About the speaker
Charite University Hospital, Berlin (Germany)
6 More presentations in this session
Professor E. Kaya (Ankara, TR)
Professor M. Taborsky (Usti Nad Labem, CZ)
Associate Professor F. Guerra (Ancona, IT)
Access the full session
The Event
ESC Congress 2018
25 August - 29 August 2018
You may be interested in
Congress Session
Congress Session
